Polo-like kinase 1, PLK1, has important functions in maintaining genome stability and is involved in regulation of mitosis. PLK1 is up regulated in many invasive carcinomas. We asked whether it may also play a role in acquisition of invasiveness, a crucial step in transition to malignancy. In a model of metaplastic basal-like breast carcinoma progression, we found that PLK1 expression is necessary but not sufficient to induce invasiveness through laminin-rich extracellular matrix. PLK1 mediates invasion via Vimentin and β1 integrin, both of which are necessary. We observed that PLK1 phosphorylates Vimentin on serine 82, which in turn regulates cell surface levels of β1 integrin.
Introduction
PLK1, is a member of the well-conserved family of polo-like kinases which has four known members in humans, PLK1,2,3,4. Silencing of PLK1 via siRNA induces apoptosis, interferes with mitosis (1, 2), inhibits centrosome amplification (3) , and down regulates response to DNA damage via BRCA2 phosphorylation (1) . PLK1 mRNA level is transiently down regulated in response to DNA damage and this is dependent on BRCA1 and its downstream effectors, CHEK1 kinases (4) .
In addition to DNA damage and mitosis, PLK1 has been implicated in the golgi checkpoint pathway that ensures proper segregation of this organelle during cell division (5) .
Consistent with its known functions, PLK1 expression is regulated during cell cycle progression: levels are low in G0, G1, and S, but begin to increase in G2 and peak in M phase (reviewed in (6) ). PLK1 is degraded via an APC dependent proteolysis pathway as cells exit mitosis. Interestingly, PLK1 phosphorylates APC, which in turn targets PLK1 for degradation. PLK1 levels are also regulated by a direct interaction with the chaperone heat shock protein Hsp90, which has recently been linked to regulation of MMP function (7, 8) . Serum induces PLK1 mRNA levels in multiple human cell lines. In general, active proliferation has been correlated with high PLK1 levels, and differentiation (induced by factors in culture) with low levels, while DNA damage acts as a transient down regulator. In normal tissues, PLK1 is found only in actively proliferating tissues such as placenta and its expression increases in many invasive carcinomas, including breast, ovarian, esophageal, head and neck, melanoma tumor specimens.
Using the HMT-3522 cell line series, comprised of the non-invasive S1
and S2, pre-invasive S3-A,-B,-C, and invasive T4-2 constituting a faithful model for the metaplastic basal-like breast cancer sub-type (9-11), here we found a role for PLK1 in invasion, described a mechanism, and propose a therapeutic strategy.
Materials and Methods
Cell culture. Cells were grown in tissue culture monolayers (2D) using (MBL international), 1:100 dilution; phospho vimentin (ser82) D095-3
(MBL International), 1:500 dilution.
Invasion assay. Invasion through lrECM (Matrigel) was measured in
Boyden chamber assays, essentially as described (12) . Figure 2B ); β1 integrin was expressed at a higher level on the surface of T4-2 cells than in S1, S2, and S3s, and its inhibition resulted in a decrease of invasiveness in a dose dependent manner ( Figure 2C ).
Effects of downregulating PLK1, vimentin, and β1 integrin function
were not additive or synergistic in any combination ( Figure 2D) suggesting that the three proteins function in the same invasion pathway.
Knocking down PLK1 down regulated the level of ser82 phosphorylated vimentin ( Figure 3A) , as well as decreasing the cell surface levels of β1 integrin ( Figure 3C ), as did knocking down vimentin ( Figure 3C ).
Expressing mutant vimentin which contained a non-phosphorylatable ser82 down regulated invasion compared to the wildtype vimentin control which had a higher level of phosphorylated ser82 ( Figure 3B ), as well as decreasing the total and activated β1 integrin levels on the cell surface ( Figure 3D ).
To explore the relevance of this PLK1-mediated invasion mechanism to tumor phenotypes in vivo, we found that downregulating PLK1 In addition to PLK1, another protein involved in maintaining genome stability, the double-strand break repair protein Ku80, has been shown to be involved in invasion (18) . Ku80 interacts with MMP9 on the cell surface, and its inhibition results in reduced invasion. PLK1 down regulation does not affect MMP9 activity (data not shown), suggesting an MMP9 independent function. In addition, we found that the centromeric protein CENPA and the double-strand break repair protein XRCC3 were involved in invasion in Boyden chamber assays, whereas the M2 subunit of ribonucleotide reductase RRM2 was not (data not shown).We have now dubbed these genes Genomic Instability and Extracellular Matrix Invasion (GISEM) genes. Targeting 
